Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

New hope for migraine

Financial Express Lucknow

|

April 06, 2025

Know about a new drug & if it is for you

- Dr PN Renjen

MIGRAINE CAN BE debilitating. However, a new drug, atogepant, which is taken orally, promises efficacy for the condition. But how effective is it? Dr PN Renjen, senior consultant, neurology, Indraprastha Apollo Hospitals, says: "Atogepant is a promising oral medication for the preventive treatment of migraines. It is a calcitonin gene-related peptide (CGRP) receptor antagonist, specifically designed to reduce the frequency of migraine days. Clinical trials, such as the advance and elevate studies, demonstrated significant efficacy in reducing monthly migraine days (MMDs) and improving functional outcomes within just weeks of treatment. In particular, atogepant showed early benefits, with reductions in weekly migraine days and improved quality-of-life measures during the first month of use. It is effective for both episodic and chronic migraines

PLUS D'HISTOIRES DE Financial Express Lucknow

Financial Express Lucknow

IMF directors urge India to replenish fiscal buffers

WHILE FISCAL CONSOLIDATION has progressed, achieving the fiscal deficit target remains challenging, necessitating disciplined spending and strengthened fiscal buffers to safeguard stability, the International Monetary Fund executive board directors in their report.

time to read

1 min

November 27, 2025

Financial Express Lucknow

New export scheme pegs interest subsidy at 3%

The Interest Equalisation Scheme (IES) for exporters which is expected to make a comeback next week will provide 2.

time to read

1 mins

November 27, 2025

Financial Express Lucknow

Kharif rice output hits record high; pulses, soya fall

THE COUNTRY'S RICE production during the kharif season that ended in October reached a record 124.

time to read

1 min

November 27, 2025

Financial Express Lucknow

Reliance JV set to build $11-bn AI data centre

· Visakhapatnam campus likely to be ready by 2030

time to read

1 min

November 27, 2025

Financial Express Lucknow

Torrent nears deal to buy L&T unit for $1.2 bn

TORRENT POWER'S TALKS to acquire Larsen & Toubro's (L&T) thermal power business are at an advanced stage, with an agreement expected to be reached before the year-end, people familiar with the discussions said.

time to read

1 min

November 27, 2025

Financial Express Lucknow

Cabinet clears rare earth magnet incentive scheme

· Homegrown value chain for sunrise industries

time to read

2 mins

November 27, 2025

Financial Express Lucknow

Exporters seek direct rupee-ruble exchange

INDIAN EXPORTERS ARE facing mounting payment delays on shipments to Russia as sanctions widen and banks grow wary of handling transactions, prompting calls for a direct rupee-ruble exchange mechanism.

time to read

1 min

November 27, 2025

Financial Express Lucknow

Data exclusivity will kill generics: Advocacy group

THE GOVERNMENT'S PLANS to introduce data exclusivity provisions in the country's drug regulatory framework pose a risk to the generics market, and could likely create monopolies in the pharma sector, an advocacy group said on Wednesday.

time to read

1 min

November 27, 2025

Financial Express Lucknow

December rush set to make 2025 the biggest IPO year

. 28 firms look to raise ₹48,000 cr next month

time to read

1 min

November 27, 2025

Financial Express Lucknow

Auto tech funding in Delhi-NCR rises fivefold in Jan-Sept

AUTO TECH FUNDING in Delhi-National Capital Region (NCR) has risen 517% in the first nine months of 2025, netting $1.3 billion compared with $218 million in the same period of 2024.

time to read

1 min

November 26, 2025

Listen

Translate

Share

-
+

Change font size